Nanoviricides, Inc.
NNVC
Revenue
0.00
0.000.00%
-Assets
12.82M
▲1.36M▲11.84%
3 Months ChangeLiabilities
1.36M
▲545.44k▲67.06%
3 Months ChangeFree Cash Flow
-1.18M
▼-102.62k▼-9.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087828
2024-05-15
Form 10-Q
ID: 0001410578-24-000843
2024-04-05
Form 8-K
ID: 0001104659-24-044367
2024-02-16
Form 8-K
ID: 0001104659-24-024973
2024-02-14
Form 10-Q
ID: 0001410578-24-000048
2024-01-19
Form 8-K
ID: 0001104659-24-005254
2023-11-14
Form 10-Q
ID: 0001410578-23-002484
2023-11-07
Form 8-K
ID: 0001104659-23-114862
2023-09-01
Form 8-K
ID: 0001104659-23-097802
2023-05-25
Form 8-K
ID: 0001104659-23-064652